SEAFORD MEDICAL PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: G81029 | SEAFORD, BN25 1DH
Showing results 451-500 of 752
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Nizatidine | 48 | 3,116 | £3.0K | +39.5% ▲ |
| Acetazolamide | 48 | 5,810 | £277 | +121.5% ▲ |
| Reboxetine | 47 | 401 | £125 | +205.2% ▲ |
| 47 | 979 | £891 | +45.3% ▲ | |
| Combined ethinylestradiol 20mcg | 46 | 3,256 | £1.1K | -11.9% ▼ |
| Duloxetine hydrochloride | 46 | 2,085 | £891 | -10.2% ▼ |
| 46 | 300 | £765 | +215.0% ▲ | |
| Fosfomycin trometamol | 45 | 53 | £245 | +58.1% ▲ |
| Ipratropium bromide | 45 | 56 | £400 | +177.5% ▲ |
| 45 | 528 | £1.9K | +119.3% ▲ | |
| Naratriptan hydrochloride | 44 | 378 | £72 | +68.3% ▲ |
| Betamethasone sodium phosphate | 44 | 3,510 | £463 | +257.9% ▲ |
| Azelastine hydrochloride | 44 | 424 | £323 | +270.2% ▲ |
| Tacrolimus | 44 | 1,740 | £1.3K | -18.4% ▼ |
| 44 | 1,578 | £396 | +199.0% ▲ | |
| Amiloride hydrochloride | 43 | 3,920 | £1.9K | +70.8% ▲ |
| 43 | 1,256 | £1.0K | +549.2% ▲ | |
| Bempedoic acid/Ezetimibe | 42 | 2,128 | £4.0K | -31.2% ▼ |
| Midazolam hydrochloride | 42 | 133 | £3.0K | +191.4% ▲ |
| Amantadine hydrochloride | 42 | 4,368 | £1.1K | +50.8% ▲ |
| Sodium chloride | 42 | 9,101 | £976 | +77.5% ▲ |
| Tafluprost | 42 | 2,250 | £916 | +126.5% ▲ |
| 42 | 10.7K | £1.1K | +98.4% ▲ | |
| Hydroxyzine hydrochloride | 41 | 2,212 | £65 | -23.0% ▼ |
| Lurasidone | 41 | 1,435 | £3.9K | +64.3% ▲ |
| Pizotifen malate | 41 | 2,896 | £138 | -50.3% ▼ |
| Alprostadil | 41 | 246 | £2.6K | +139.7% ▲ |
| Benzydamine hydrochloride | 41 | 8,670 | £245 | -47.0% ▼ |
| Chlorhexidine gluconate | 41 | 14.2K | £138 | +86.7% ▲ |
| 41 | 625 | £1.9K | +4.2% ▲ | |
| 40 | 301 | £505 | +142.4% ▲ | |
| 40 | 2,900 | £9.6K | +78.5% ▲ | |
| Labetalol hydrochloride | 39 | 3,134 | £328 | +71.8% ▲ |
| Alogliptin | 39 | 2,184 | £2.0K | -84.6% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 39 | 47.3K | £730 | +70.2% ▲ |
| Mefenamic acid | 39 | 2,582 | £479 | -13.7% ▼ |
| Methocarbamol | 39 | 4,100 | £261 | -18.5% ▼ |
| Loteprednol etabonate | 39 | 270 | £283 | +321.7% ▲ |
| Sennosides | 38 | 15.4K | £328 | +23.0% ▲ |
| Bempedoic acid | 38 | 1,862 | £3.5K | +15.9% ▲ |
| Eslicarbazepine acetate | 38 | 5,691 | £3.3K | +70.3% ▲ |
| Norethisterone | 38 | 2,234 | £374 | -21.7% ▼ |
| Dutasteride | 38 | 2,156 | £174 | -26.0% ▼ |
| Mycophenolate mofetil | 38 | 7,056 | £1.7K | -6.1% ▼ |
| Imiquimod | 38 | 671 | £2.4K | +434.7% ▲ |
| Amorolfine hydrochloride | 38 | 235 | £292 | +64.6% ▲ |
| 38 | 2,025 | £6.3K | +108.4% ▲ | |
| 38 | 9,420 | £1.9K | -3.3% ▼ | |
| Metoprolol tartrate | 37 | 2,940 | £857 | -27.1% ▼ |
| Liothyronine sodium | 37 | 2,912 | £6.1K | +73.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.